Fintel reports that on January 9, 2026, Citigroup initiated coverage of Vor Biopharma (NasdaqGS:VOR) with a Buy ...
The average one-year price target for Vor Biopharma (NasdaqGS:VOR) has been revised to $37.13 / share. This is a decrease of ...
In February, after 53 years, humans could launch to the moon again for the first time. NASA is now beginning the final ...
Vor Biopharma is initiated to "Hold" rating as topline phase 3 MG data for telitacicept is expected in H1 2027. Telitacicept demonstrated a best-in-disease MG-ADL reduction of -4.8 at week 24 and -7.5 ...
Kupfer hat seine beeindruckende Rally fortgesetzt, nachdem das Industriemetall erstmals die Preismarke von 13.000 Dollar pro Tonne überschritten hat. Investoren positionieren sich zunehmend für ein ...
Aon Global Limited (f/k/a Aon plc) (the "Company"), a wholly owned subsidiary of Aon plc (NYSE:AON) ("Aon") today announced that ...
UCSD's Dr. Davey Smith, former ACTIV-2 Protocol Chair, endorses 'Xafty' as "The weapon to end the virus war." - Announces "One Drug, Two Tracks" strategy: Targeting ...
The Punch on MSN
Aviation professionals outline paths to sector recovery
Experts discuss urgent reforms needed for Nigeria's aviation sector, citing poor infrastructure, weak regulation, and ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
The first $2 bills were issued by the federal government in 1862 and initially featured Alexander Hamilton. Features like rare seal colors, low serial numbers, and printing errors can increase a ...
U.S. Attorney for the District of Columbia Jeanine Pirro spent the week defending her office’s criminal investigation into ...
If you'd like to learn more about the writers and editors who contributed to this wiki, head to our About IGN's RDR2 Guide Writers page. If you found this expert guide written by our team of writers ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results